Given the significant negative correlation between the inflammatory tumor microenvironment, IL-8 expression, and the efficacy of immune checkpoint inhibitors, we further investigated whether combining mannose with immune checkpoint inhibitors could enhance antitumor effects. The gene discussed is CXCL8; the disease is neoplasm.